Changes to Oregon's CBN Rules
DEA Presents on Delta-8 Concerns!
FDA Stakeholder Call Outcome: A New Way Forward for Cannabidiol and Other Hemp Products
CBD Bills Reintroduced in 118th Congress
OLCC Leader Ousted in Agency Scandal
OLCC Recalls Expanded on Cannabis Vape Products
DEA Declares THCO a Schedule I Substance
FDA Requests Congressional Action on CBD Products